Brain Cancer

Knowledge is power. Are you facing a new diagnosis, recurrence, living with metastatic disease, or supporting a loved one through their cancer journey? The Cancer Connect Brain Cancer Information Center has current, evidence-based information for you. Get the facts about brain cancer early detection, treatment, and survivorship, and stay up to date with ongoing brain cancer research that could impact your treatment decisions through our daily cancer news.

CancerConnect Brain Cancer Community & Discussions

You are not alone—The CancerConnect Brain Cancer Community is the leading Social Media Application for Brain Cancer patients and caregivers seeking information, inspiration, and support in the wake of a cancer diagnosis. With over 50,000 members the network offers patients and caregivers a thriving community to support the many ongoing needs from diagnosis to survivorship. Login or register here.

BRAIN CANCER NEWS TIPS & FEATURES

Can Lasers Be Used to Treat ‘Inoperable’ Brain Tumors?

December 7th, 2016

Can Lasers Be Used to Treat ‘Inoperable’ Brain Tumors?

Brain surgery to remove many tumors is often complicated in that surgery will damage areas of the brain necessary for many essential life skills and […]


Temodar® After Radiation Improves Survival in Anaplastic Gliomas

June 7th, 2016

Temodar® After Radiation Improves Survival in Anaplastic Gliomas

The use of the chemotherapy agent Temodar (temozolomide) following radiation therapy significantly improves time to cancer progression and overall survival among patients with newly diagnosed […]


Genetically Modified Poliovirus Granted “Breakthrough” by FDA for Glioblastoma

May 23rd, 2016

Genetically Modified Poliovirus Granted “Breakthrough” by FDA for Glioblastoma

The United States Food and Drug Administration (FDA) has granted “breakthrough status” designation for the treatment of glioblastoma containing a genetically modified poliovirus. Glioblastoma is […]


Avastin®/Camptosar® Improves Outcomes Compared with Temodar® in Glioblastoma

May 12th, 2016

Avastin®/Camptosar® Improves Outcomes Compared with Temodar® in Glioblastoma

The treatment combination consisting of Avastin (bevacizumab) plus Camptosar (irinotecan) improves time to cancer progression compared to treatment with Temodar (temozolomide) in patients with newly […]


Data Safety and Monitoring Board Recommends Celldex's Phase 3 Study of RINTEGA® in Newly Diagnosed Glioblastoma Be Discontinued

March 7th, 2016

Data Safety and Monitoring Board Recommends Celldex’s Phase 3 Study of RINTEGA® in Newly Diagnosed Glioblastoma Be Discontinued

Celldex Therapeutics, Inc. announced today that the independent Data Safety and Monitoring Board (DSMB) has determined, based on a preplanned interim analysis, that continuation of […]


Immune Therapy for Brain Tumors: A New Promising Avenue

February 17th, 2016

Immune Therapy for Brain Tumors: A New Promising Avenue

Glioblastoma is a particularly aggressive type of brain cancer. Only about one-fifth of adults diagnosed with it survive two years or more after their diagnosis. […]


Combination of Radiation and Chemotherapy Improves Survival For Certain Types of Brain Cancer

January 29th, 2016

Combination of Radiation and Chemotherapy Improves Survival For Certain Types of Brain Cancer

Excerpted from: Advances in Cancer Research And Treatment: 2015 Year In Review Patients with a low-grade type of brain cancer known as low grade glioma may […]


Long-Term Survival Benefit Demonstrated with RINTEGA® in Recurrent Glioblastoma

November 24th, 2015

Long-Term Survival Benefit Demonstrated with RINTEGA® in Recurrent Glioblastoma

Mature survival data from a randomized, double-blind Phase 2 clinical study evaluating RINTEGA® (rindopepimut) in patients with EGFRvIII-positive, recurrent glioblastoma (GBM) were recently presented at […]


GBM AGILE: A Next-Generation Clinical Trial for Brain Cancer

November 13th, 2015

GBM AGILE: A Next-Generation Clinical Trial for Brain Cancer

Glioblastoma Multiforme (GBM) is a devastating disease. The deadliest and most aggressive form of brain tumor, GBM is expected to claim the lives of 12,000 […]


Optune Approved for Newly Diagnosed Glioblastoma Multiforme

October 22nd, 2015

Optune Approved for Newly Diagnosed Glioblastoma Multiforme

The United States Food and Drug Administration has expanded the approval of the Optune device for the treatment of patients with newly diagnosed glioblastoma multiforme. […]


More News →